Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 8/20 | 0.57 |
| ▸ | PTPRC | P08575 | 1/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.46 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8624119 | 1.00 | HIF1A (0.57) | HIF1APTPRCPTPN1FFAR1FFAR4 | |
| SCHEMBL8623308 | 0.92 | HIF1A (0.65) | HIF1APTPRCPTPN1ALDH1A1MAOB | |
| SCHEMBL8623305 | 0.92 | HIF1A (0.65) | HIF1APTPRCPTPN1ALDH1A1MAOB | |
| SCHEMBL4564428 | 0.89 | HIF1A (0.71) | HIF1AFFAR1FFAR4MEN1KMT2A | |
| SCHEMBL8618325 | 0.89 | HIF1A (0.58) | HIF1APTPRCPTPN1ALDH1A1HPGD | |
| SCHEMBL8618321 | 0.89 | HIF1A (0.58) | HIF1APTPRCPTPN1ALDH1A1HPGD | |
| SCHEMBL8621331 | 0.86 | HIF1A (0.65) | HIF1AMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL8621229 | 0.86 | HIF1A (0.59) | HIF1AHPGDNPC1RAB9AMAPT | |
| SCHEMBL8621231 | 0.86 | HIF1A (0.59) | HIF1AHPGDNPC1RAB9AMAPT | |
| SCHEMBL28895893 | 0.86 | HIF1A (0.63) | HIF1APTPRCPTPN1MAOBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080200334-A1 | Method For Enhancing The Effectiveness Of Ethaboxam | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-21 | — | — | US | disclosed |
| EP-0951831-B1 | Fungicidal co-formulation | BASF AG (DE) | 2003-06-11 | — | — | EP | disclosed |
| EP-0951831-A1 | Fungicidal co-formulation | American Cyanamid Company (US) | 1999-10-27 | — | — | EP | disclosed |
| EP-0658541-B1 | PROCESS FOR PRODUCING CARBOXYLIC ACID DERIVATIVE | SHIONOGI & CO (JP) | 1998-05-20 | — | — | EP | disclosed |
| US-5510506-A | Process for producing carboxylic acid derivatives | SHIONOGI & CO., LTD. (JP) | 1996-04-23 | — | — | US | disclosed |
| EP-0658541-A1 | PROCESS FOR PRODUCING CARBOXYLIC ACID DERIVATIVE | SHIONOGI & CO., LTD. (JP) | 1995-06-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080200334-A1 | Method For Enhancing The Effectiveness Of Ethaboxam | MANBA, MAN2A1, CMA1 | HIF1A 4679/4885PTPRC 2859/4885PTPN1 2649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.